Literature DB >> 7046643

Immunology of human dermatophyte infections.

A R Ahmed.   

Abstract

Human infection is the result of a complex interplay of factors pertaining to the invading organism, the host, and the environment. This is best shown in human dermatophyte infections. Acute infections are usually short-lived and easy to treat. The patient has good cell-mediated immunity, short-term antidermatophyte antibodies, and delayed hypersensitivity. In chronic infections, the infection is long-term and resistant to therapy. Patients have poor in vitro assessed cell-mediated immunity and immediate hypersensitivity to fungal antigens. Antidermatophyte antibodies usually do not disappear quickly. Development of more specific and sensitive assays will add to our understanding of this unique host-parasite relationship. The speculative role of anti-idiotypic antibodies is discussed.

Entities:  

Mesh:

Year:  1982        PMID: 7046643

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  5 in total

Review 1.  Urticaria and angioedema.

Authors:  B A Burrall; A C Huntley
Journal:  Clin Rev Allergy       Date:  1985-02

2.  The inhibitory effect of PUVA on the immunity of experimental dermatophytosis in guinea pigs.

Authors:  T Okuwa; T Horio
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

3.  Possible Role of Trichophytin Antigen in Inducing Impaired Immunological Clearance of Fungus in Onychomycosis.

Authors:  Chhavi Gupta; Shukla Das; V G Ramachandran; Rumpa Saha; S N Bhattacharya; Sajad Ahmad Dar; Dharmendra Atri
Journal:  Mycopathologia       Date:  2015-11-27       Impact factor: 2.574

4.  Class-specific antibody in human dermatophytosis reactive with Trichophyton rubrum derived antigen.

Authors:  T Hamouda; C D Jeffries; E M Ekladios; A M el-Mishad; M el-Koomy; N Saleh
Journal:  Mycopathologia       Date:  1994-08       Impact factor: 2.574

5.  Pathogenesis of dermatophytoses.

Authors:  Ram Tainwala; Yk Sharma
Journal:  Indian J Dermatol       Date:  2011-05       Impact factor: 1.494

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.